Specialty Pharma Journal Specialty, Precision & Technology

Respiratory biotech Pulmatrix announced an agreement to merge with publicly traded, biopharmaceutical company Ruthigen. The …

Today, Novartis announced that the European Commission (EC) has approved Jakavi (ruxolitinib) for the treatment …

Janssen Biotech, Inc. and partner Pharmacyclics, Inc. announced that an Independent Data Monitoring Committee determined …

TAMPA, FL, March 16, 2015 — The biosimilars event of the year – Biosimilars 20/20 …

South Korea’s Samsung Bioepis Co., Ltd. recently announced that it has submitted a marketing authorization …

Today, Cancer drugmaker ADC Therapeutics Sarl announced that it has filed its first application to …

After Endo International offered a rival bid, Valeant Pharmaceuticals International announced that it has raised …

The US Food and Drug Administration (FDA) has accepted for review Bristol-Myers Squibb’s (BMS) resubmitted …

Today, Baxter International Inc. announced positive results from its late-stage trial evaluating its investigational treatment …

Pioneer in computer-aided dysmorphology analysis, FDNA, announced that it will launch an online forum for …

Early detection of cancer is critical and can significantly improve survival for most cancer types. …

The Centers for Medicare & Medicaid Services (CMS) is launching a Next Generation Accountable Care …

Today, Neuralstem, Inc. announced top-line data from a mid-stage trial evaluating its investigational amyotrophic lateral …

Google-backed genetic-testing company 23andMe is launching its own drug development unit, and bringing on former …

Today, Endo International plc confirmed that it has made a takeover bid for Salix Pharmaceuticals …